Aripiprazole in the Treatment of Tourette's Syndrome

Stopped early · Not applicable

Conditions studied: Tourette's Syndrome

In brief

This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.

Key facts

Study ID
NCT00282139
Run by
University of Florida
People needed
40
Starts
2004-01-01
Expected to finish
2006-10-01
Last updated by the study team
2011-10-05

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.